Prediction Case File
YouTubeEvaluation Complete

SPDR Gold Shares ETF Prediction and Forecast [GLD]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.us27 Jan 2026, 04:47 UTC
Video preview for SPDR Gold Shares  ETF Prediction and Forecast [GLD]
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The SPDR Gold Shares ETF (GLD) shows positive short-term signals from moving averages and MACD, with support identified at $458.00 and resistance at $473.70. The RSI indicates potential overbought conditions, but overall, the trend is bullish. A buy signal from a pivot bottom 16 days ago and recent price appreciation suggest further upside. However, due to some minor weaknesses, the recommendation is a 'Hold/Accumulate' rather than a strong buy, with a suggested stop-loss at $446.77.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

StockInvest.us

Tracked signals
1521
Historical success
43.3%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.